mAb Development

Jun 21, 2018
By BioPharm International Editors
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
Apr 17, 2018
By BioPharm International Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
Apr 11, 2018
By BioPharm International Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 08, 2018
By BioPharm International Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Feb 14, 2018
By BioPharm International Editors
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
Feb 01, 2018
BioPharm International
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
Jan 31, 2018
By BioPharm International Editors
The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.
Jan 23, 2018
By BioPharm International Editors
The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.
Jan 12, 2018
By BioPharm International Editors
An antibody-based Zika virus therapeutic that protected monkeys from infection might be safe enough for administration to pregnant women.
native1_300x100
lorem ipsum